SUMMER AND WINTER VITAMIN D3 LEVELS IN SEVEN PLATYRRHINE SPECIES HOUSED AT A BRITISH ZOO, WITH REFERENCE TO NATURAL UVB LEVELS.

Serum samples were collected from 24 platyrrhines of seven diurnal species housed with outdoor access at Bristol Zoo Gardens (United Kingdom) to test 25-hydroxyvitamin D3 (25OHD3) levels as part of the veterinary department's preventative health care program. Samples were collected in August 2008 (summer) and January 2009 (winter) to examine the effect of season on 25OHD3 levels. Dietary levels of vitamin D3 remained the same throughout the study period and fell within the range of 2000-4000 IU/kg dry matter, in accordance with current primate guidelines. Statistical analysis showed that there was no significant difference between the platyrrhines' summer 25OHD3 values (range, <4.0->150.0 µg/L) and winter 25OHD3 values (range, <4.0-80.1 µg/L). However, ultraviolet B (UVB) measurements taken at the zoo during the study period confirmed that UVB levels were significantly higher in summer (mean reading for 1200-1300 hours GMT time period, 153.8 µW/cm2) compared with winter (mean reading for 1200-1300 hours GMT time period, 19.4 µW/cm2). The 25OHD3 levels measured were generally found to be low compared with previously published values from healthy captive and wild platyrrhines.

Novel polyomaviruses of nonhuman primates: genetic and serological predictors for the existence of multiple unknown polyomaviruses within the human population.

Polyomaviruses are a family of small non-enveloped DNA viruses that encode oncogenes and have been associated, to greater or lesser extent, with human disease and cancer. Currently, twelve polyomaviruses are known to circulate within the human population. To further examine the diversity of human polyomaviruses, we have utilized a combinatorial approach comprised of initial degenerate primer-based PCR identification and phylogenetic analysis of nonhuman primate (NHP) polyomavirus species, followed by polyomavirus-specific serological analysis of human sera. Using this approach we identified twenty novel NHP polyomaviruses: nine in great apes (six in chimpanzees, two in gorillas and one in orangutan), five in Old World monkeys and six in New World monkeys. Phylogenetic analysis indicated that only four of the nine chimpanzee polyomaviruses (six novel and three previously identified) had known close human counterparts. To determine whether the remaining chimpanzee polyomaviruses had potential human counterparts, the major viral capsid proteins (VP1) of four chimpanzee polyomaviruses were expressed in E. coli for use as antigens in enzyme-linked immunoassay (ELISA). Human serum/plasma samples from both Côte d'Ivoire and Germany showed frequent seropositivity for the four viruses. Antibody pre-adsorption-based ELISA excluded the possibility that reactivities resulted from binding to known human polyomaviruses. Together, these results support the existence of additional polyomaviruses circulating within the human population that are genetically and serologically related to existing chimpanzee polyomaviruses.